PRESCRIPTION medicines spending in America grew 4.8% in 2016 to US$323 billion - less than half the growth rate of the previous two years, according to a new report from QuintilesIMS.
The company said new medicines introduced since 2014 continue to drive at least half of total spending growth "as clusters of innovative treatments for cancer, autoimmune diseases, HIV, multiple sclerosis and diabetes become accessible to patients".
The above article was sent to subscribers in Pharmacy Daily's issue from 08 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 May 17
